Matei Horea Vladi, Vica Mihaela Laura, Siserman Costel Vasile
a Department of Cell and Molecular Biology , 'Iuliu Haţieganu' University of Medicine and Pharmacy , Cluj-Napoca , Romania.
b Molecular Biology Laboratory , Legal Medicine Institute , Cluj-Napoca , Romania.
Immunol Invest. 2018 Oct;47(7):735-744. doi: 10.1080/08820139.2018.1489832. Epub 2018 Jul 6.
Infection with hepatitis B virus (HBV) is a major problem worldwide. The major histocompatibility complex plays an essential role in host immunity and can help eliminate the HBV of infected hepatocytes. Our study aimed to determine the role of certain human leukocyte antigen (HLA) class II molecules (i.e. HLA-DRB1 and HLA-DQB1) in the persistence or removal of HBV. Sixty patients confirmed to be HBV-positive via real-time polymerase chain reaction (PCR), i.e. people with chronic active hepatitis, were included in the study along with a control group of 100 healthy individuals without evidence of HBV infection. The DNA was subsequently used to determine HLA-DRB1 and HLA-DQB1 low-resolution typing genetic profile via PCR amplification. The univariate analysis performed revealed significant association of the HLA-DRB103 and HLA-DQB105 alleles to the infected persons (study group), while HLA-DRB1*01 was shown to be protective against HBV infection. To our knowledge, this is the first Romanian study associating HLA with HBV, and it can provide valuable insight concerning the relationship between genetic factors and immune response in the sampled population.
乙型肝炎病毒(HBV)感染是一个全球性的主要问题。主要组织相容性复合体在宿主免疫中起着至关重要的作用,并有助于清除受感染肝细胞中的HBV。我们的研究旨在确定某些人类白细胞抗原(HLA)II类分子(即HLA-DRB1和HLA-DQB1)在HBV持续存在或清除中的作用。通过实时聚合酶链反应(PCR)确诊为HBV阳性的60名患者,即慢性活动性肝炎患者,与100名无HBV感染证据的健康个体组成的对照组一起纳入研究。随后,通过PCR扩增,利用该DNA来确定HLA-DRB1和HLA-DQB1低分辨率分型遗传图谱。进行的单因素分析显示,HLA-DRB103和HLA-DQB105等位基因与感染者(研究组)存在显著关联,而HLA-DRB1*01显示对HBV感染具有保护作用。据我们所知,这是罗马尼亚第一项将HLA与HBV相关联的研究,它可以为所研究人群中遗传因素与免疫反应之间的关系提供有价值的见解。